VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 374 filers reported holding VANECK VECTORS ETF TR in Q2 2017. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,410,829 | -16.8% | 2,802,335 | -7.0% | 0.05% | -18.5% |
| Q2 2023 | $90,690,951 | +6.0% | 3,011,988 | +13.9% | 0.06% | -1.5% |
| Q1 2023 | $85,566,231 | +21.4% | 2,645,015 | +7.5% | 0.07% | +10.0% |
| Q4 2022 | $70,496,099 | +33.9% | 2,459,738 | +12.7% | 0.06% | +17.6% |
| Q3 2022 | $52,666,000 | -17.1% | 2,183,515 | -5.9% | 0.05% | -15.0% |
| Q2 2022 | $63,504,000 | -27.3% | 2,319,384 | +1.8% | 0.06% | -20.0% |
| Q1 2022 | $87,347,000 | +48.1% | 2,277,638 | +23.7% | 0.08% | +50.0% |
| Q4 2021 | $58,996,000 | +7.7% | 1,841,899 | -0.9% | 0.05% | -2.0% |
| Q3 2021 | $54,765,000 | -19.5% | 1,858,339 | -7.2% | 0.05% | -26.1% |
| Q2 2021 | $68,011,000 | +15.7% | 2,001,496 | +10.6% | 0.07% | +1.5% |
| Q1 2021 | $58,800,000 | -12.3% | 1,809,234 | -2.8% | 0.07% | -21.8% |
| Q4 2020 | $67,034,000 | -21.1% | 1,861,032 | -14.3% | 0.09% | -34.6% |
| Q3 2020 | $85,007,000 | +50.9% | 2,170,755 | +41.4% | 0.13% | +35.7% |
| Q2 2020 | $56,322,000 | +70.2% | 1,535,508 | +6.9% | 0.10% | +38.0% |
| Q1 2020 | $33,095,000 | -28.9% | 1,436,417 | -9.6% | 0.07% | -16.5% |
| Q4 2019 | $46,524,000 | +1.5% | 1,588,938 | -7.4% | 0.08% | -8.6% |
| Q3 2019 | $45,840,000 | +18.1% | 1,716,204 | +13.1% | 0.09% | +12.0% |
| Q2 2019 | $38,799,000 | +26.4% | 1,517,961 | +10.9% | 0.08% | +18.6% |
| Q1 2019 | $30,685,000 | +49.8% | 1,368,652 | +40.9% | 0.07% | +29.6% |
| Q4 2018 | $20,479,000 | +73.0% | 971,030 | +52.0% | 0.05% | +92.9% |
| Q3 2018 | $11,835,000 | -26.3% | 639,025 | -11.2% | 0.03% | -33.3% |
| Q2 2018 | $16,061,000 | -1.9% | 719,904 | -3.3% | 0.04% | -6.7% |
| Q1 2018 | $16,371,000 | -3.3% | 744,803 | +2.2% | 0.04% | -13.5% |
| Q4 2017 | $16,938,000 | +6.1% | 728,845 | +4.8% | 0.05% | -7.1% |
| Q3 2017 | $15,960,000 | +7.2% | 695,133 | +3.1% | 0.06% | 0.0% |
| Q2 2017 | $14,883,000 | -17.8% | 674,060 | -13.7% | 0.06% | -54.5% |
| Q1 2017 | $18,115,000 | -2.0% | 780,828 | -8.1% | 0.12% | -12.8% |
| Q4 2016 | $18,484,000 | -30.7% | 849,443 | -25.5% | 0.14% | -44.3% |
| Q3 2016 | $26,678,000 | -21.1% | 1,140,077 | +3.0% | 0.25% | -11.5% |
| Q2 2016 | $33,831,000 | – | 1,106,668 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |